The FY2024 (Dec) proxy of Medpace Holdings names 12 peer companies for pay. Among Medpace Holdings and these peers, CEO pay was 4th highest of 5 and total shareholder return was the highest of 5.
4th highest of 5in Medpace Holdings and its pay peers, FY2024 (Dec) by CEO pay:
$5.5M$26.7M
1st highest of 5in Medpace Holdings and its pay peers, FY2024 (Dec) by total shareholder return:
$117$395
Pay peer group, FY2024 (Dec) proxy
| Iqvia Holdings | ||
| Labcorp Holdings | ||
| Revvity | ||
| Bruker | ||
| Agilent Technologies | Not disclosed | Not disclosed |
| BIO-TECHNE | Not disclosed | Not disclosed |
| Catalent, Inc. | Not disclosed | Not disclosed |
| Charles River Laboratories | Not disclosed | Not disclosed |
| Fortrea Holdings Inc. | Not disclosed | Not disclosed |
| ICON plc | Not disclosed | Not disclosed |
| Quest Diagnostics | Not disclosed | Not disclosed |
| Sotera Health Company | Not disclosed | Not disclosed |
12 companies
Changes by year
FY2025 (Dec) proxy
- RemovedCatalent, Inc.pay peer groupbecause it was acquired by Novo Holdings A/S in 2024
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.